SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QGLY - Funny Name Great Product. -- Ignore unavailable to you. Want to Upgrade?


To: Gary Clarke who wrote (7219)1/21/1998 3:17:00 PM
From: William, III  Read Replies (3) | Respond to of 8960
 
I can't believe how quiet this thread has become. I bought some QGLY back in October at 18 1/2 and sold in November for a small 2 point gain. At the time I thought I would start salivating if it fell to these levels. Now here it is and I'm not so sure. My rationale is the following:

1) The stock has still almost doubled in price and there are lots of profit takers.

2) It is still seen as a risky investment because it is still listed on the NASDAQ bulletin board and not on the National Market System.

2) Zinc has still not proven itself to the medical community and is seen as a placebo. (Surely this isn't it).

3) It is feared that this stock will be too cyclical and will do well only in cold seasons (but if that was the case it would be doing quite well right now - unless no one wants to buy for fear of a Spring slowdown).

My guess is reasons 1 and 2 which would make this a golden opportunity - any thoughts?